After 50 a checkup changes its meaning. Up to that age it was largely about preventing problems in the future; now it is about catching early what may already have started and is not yet making itself felt. Atherosclerosis, disturbed carbohydrate metabolism, loss of bone mass, bowel polyps — all of them build for years without symptoms, and they are caught not by how you feel but by a calendar of examinations.
There is one illusion worth losing straight away: that after 50 you should “test everything.” A checkup after 50 is not thirty tubes once a year but a short annual set plus a few screening examinations, each with its own interval. And the most valuable items on that list are not blood tests at all — colonoscopy, mammography and low-dose CT of the lungs in smokers save lives; an extended biochemistry panel and a tumor marker panel do not.
We will go through it in order: what makes up the shared base for everyone, what is added for men and for women, what national screening programs usually cover, and what is worth declining. We do not retell the individual markers here — each one has its own page in the lab test reference — this piece is about how they add up into a schedule.
What changes after 50 — and why the set from 40 no longer covers it
By fifty, three groups of changes have accumulated, and each needs its own instrument.
Vessels and metabolism. The lipid profile shifts, insulin resistance grows, blood pressure steps outside the normal range more and more often. For women there is an additional factor — menopause: as estrogen goes, so does its protective effect on the vessels, and cholesterol and triglycerides can worsen even with no change in diet.
Cancer risk. Age is the main non-modifiable risk factor for most tumors. That is precisely why almost every screening program starts to apply after 50: colorectal cancer, breast cancer, lung cancer in smokers. The point is to catch the asymptomatic stage, when treatment works best.
Bones and muscle. Loss of bone mass accelerates in the first years after menopause in women, and proceeds more slowly but just as steadily in men. A hip fracture at 70 is the result of a process that began at 50.
The practical conclusion: the basic annual set — we went through it in the piece on the essential annual check-up lab tests — remains the foundation, but on its own it is no longer enough after 50. A screening part is added to it, with its own logic and its own intervals.
The base for everyone: the annual set after 50
This list is the same for men and women and covers the main chronic risks. It is deliberately short.
| What | Why |
|---|---|
| Complete blood count | Anemia, inflammation, changes in hemoglobin and white blood cells |
| Glycated hemoglobin or fasting glucose | Diabetes and prediabetes — often without symptoms |
| Full lipid panel: total cholesterol, LDL, HDL, triglycerides | Cardiovascular risk |
| Creatinine with a calculated eGFR | Kidney function, drug safety |
| ALT, AST, GGT | Liver: fatty liver disease, alcohol, medicines |
| TSH | Thyroid — a frequent source of complaints written off as age |
| Vitamin D | Bones and muscles; deficiency is widespread at northern latitudes |
| Urinalysis | Kidneys, hidden infection, protein |
| Blood pressure, weight, waist circumference | The cheapest and most informative measurements there are |
An honest caveat about the last two lab items on that list: mass screening by TSH and vitamin D is not confirmed by international guidance — the USPSTF considers the evidence insufficient both for checking thyroid function in people without symptoms and for measuring vitamin D levels. In everyday practice both tests are usually part of the familiar annual set: they are inexpensive, and vitamin D deficiency and subclinical hypothyroidism are common at this age and in low-sunlight regions. That is a reasonable local habit rather than evidence-based screening on the level of lipids, glucose and blood pressure — and it is worth discussing them with a doctor in exactly that status.
Two frequent mistakes. The first is measuring total cholesterol alone: after 50 a full lipid panel is what is needed, and with a loaded family history it makes sense to look once at lipoprotein(a) and apolipoprotein B (more on this in the piece on cardiac markers). The second is ignoring blood pressure: hypertension after 50 affects the majority and stays symptom-free until the complications arrive, while a blood pressure monitor costs less than any panel.
Wizey’s chief medical officer, Dr. Aigerim Bissenova, notes that when the complaint after 50 is fatigue and “age-related” weakness, the answer is not to extend the panel indefinitely but to close three things first: ferritin, vitamin B12 and TSH — in practice these explain such symptoms more often than anything else.
Cancer screening that genuinely lowers mortality
This is the most important part of a checkup after 50 — and the part most often skipped, because it is less pleasant than giving blood.
Bowel. Colorectal cancer screening works better than most, because it finds not only cancer but the polyps that can be removed before they turn. Under the USPSTF recommendation screening begins at 45, and for ages 50 to 75 it carries the highest level of evidence (grade A). The options are equivalent: colonoscopy every 10 years, an annual fecal immunochemical test, a stool DNA test every 1–3 years, CT colonography or sigmoidoscopy every 5 years. The best test is the one you will actually do.
Lungs. An annual low-dose CT scan is recommended for people aged 50 to 80 with a smoking history of at least 20 pack-years who smoke now or quit less than 15 years ago — that is a separate USPSTF recommendation. An ordinary chest X-ray is not fit for this job: it does not find early tumors. If you smoked a pack a day for twenty years, this item is yours, whatever your sex.
A separate caveat about the visual examination. Inspection of the skin, of the lips and mouth, and palpation of the thyroid and lymph nodes are part of an ordinary preventive check-up, but unlike the three screenings above, there is no evidence that they lower mortality — the USPSTF considers the data insufficient. That is not a reason to refuse: the examination takes five minutes and usually costs nothing extra. It simply is not the equal of a full screening program.
What men add after 50
PSA is the most contested item in a man’s checkup. The conversation about it is worth having with your eyes open. Under the USPSTF recommendation — a 2018 document, currently being updated — for men aged 55 to 69 the decision about periodic PSA screening should be an individual one: screening gives a small reduction in prostate cancer mortality, but at the cost of false positives, biopsies and the detection of tumors that would never have declared themselves. After 70, routine screening is not recommended.
The practical advice: do not interpret a single PSA value on your own. It rises with prostatitis, with benign enlargement of the prostate, after a bike ride and even after ejaculation the day before. A raised result is a reason to repeat the test and see a urologist, not to draw conclusions at home.
Abdominal aortic aneurysm. Men aged 65 to 75 who have ever smoked are advised to have a one-off ultrasound of the abdominal aorta — a simple examination that finds a symptom-free widening of the vessel. At 50 it is not yet due, but it is useful to know about in advance.
Testosterone — on symptoms only. Mass screening is not needed. Testosterone (in the morning, ideally twice, together with SHBG) is worth checking for a specific picture: a persistent drop in libido, erectile dysfunction, loss of muscle mass, fatigue. What belongs in the male minimum at a younger age is set out in the piece on the men’s health checkup after 30.
What women add after 50
Mammography. Under the updated 2024 USPSTF recommendation it is done from 40 to 74, every two years. Some professional bodies propose an annual interval — that is worth discussing with a doctor in light of breast density and family history. National programs differ in where they set the upper age limit, so it is worth checking the ages your own program uses.
Cervix. Screening continues. Under the USPSTF recommendation, women aged 30 to 65 have three equivalent options: cytology every 3 years, a high-risk HPV test every 5 years, or co-testing (HPV plus cytology) every 5 years. After 65 screening can be stopped if the previous screening was adequate and there is no elevated risk — which makes the years just before 65 exactly the ones not to skip.
Bones. This is where a new item appears after 50. Under the 2025 USPSTF recommendation, densitometry (DXA) is performed in all women from 65, and in postmenopausal women under 65 when the risk is raised; among the risk factors named are menopausal status itself, low body weight, a parent who fractured a hip, smoking and heavy alcohol use. An important detail: if a fracture after minimal trauma has already happened, or bone density is falling on long-term glucocorticoids, that is no longer screening — such situations are handled as diagnosis and treatment, outside screening intervals. For men the data are still insufficient, and that is not a prohibition but an admission of a gap in the evidence.
Lipids and the heart after menopause. A few years after the last period, cardiovascular risk in women catches up with men’s, and the lipid panel turns from a formality into an important item. What exactly to revisit in this period is in the piece on menopause, lipids, bones and the heart, and the logic of broadening the set before 50 is in the breakdown of the women’s checkup after 40.
Thyroid and iron. Hypothyroidism is more common in women over 50, and iron stores after heavy perimenopausal cycles often stay low — TSH and ferritin are worth keeping in the annual set.
What national screening programs cover — and what you arrange yourself
A large part of a checkup after 50 is not something you have to organize from scratch. Most countries run population screening programs, and within them the examinations are usually free or heavily subsidized at the recommended ages. What is covered, from what age and how often differs from country to country — the age windows and intervals in this article are international reference points, not your local schedule, so check them against your own national program.
The overall shape is broadly similar, though. Three cancer screenings are the ones national programs are usually built around:
- Colorectal screening — a stool test for occult blood at short intervals or endoscopy at long ones, often organized as a test kit mailed to your home.
- Mammography — invitations on a fixed interval, most commonly every two years, within an age window that varies by country.
- Cervical screening — cytology and, increasingly, HPV testing; the USPSTF lists both as equivalent options from 30 to 65, and programs have been shifting toward HPV as the primary test.
Beyond those three, coverage thins out. Low-dose CT for long-term smokers is the newer addition: some countries have national programs, others are still running pilots, and in many places it is not offered at all — if you meet the criteria above and your program does not include it, raise it with a doctor yourself. PSA is the exception in the other direction: it is generally handled as a shared decision between a man and his doctor rather than as an organized population program, which is exactly how the USPSTF frames it.
The second thing worth understanding is that a general health check is not the same thing as cancer screening, and is usually narrower than people expect. The NHS Health Check in England is a good illustration: it is offered to adults aged 40 to 74 once every five years and covers height, weight and waist, blood pressure, cholesterol and sometimes blood sugar. Useful — but that is the whole of it.
Which means the annual set from the beginning of this article is largely something you arrange yourself: a full lipid panel rather than total cholesterol alone, glycated hemoglobin, creatinine with eGFR, liver enzymes, TSH, vitamin D and ferritin — plus, with a loaded family history, a one-off ApoB and Lp(a). And a low-dose CT if you are a long-term smoker and your program does not invite you to one.
What should not be in a checkup after 50
Three categories of the superfluous, and they absorb the most money and nerves.
Tumor markers “just in case.” CEA, CA-125, CA 19-9 and the rest are not fit for screening people without symptoms: they rise with inflammation, smoking and benign tumors, and often stay normal when there is a real cancer. The result is either unnecessary CT scans and biopsies or false reassurance. A detailed breakdown is in the piece on which tumor markers are actually worth testing and which only frighten you.
A “full body work-up” in a single package. Panels of 60 to 100 markers are guaranteed to throw up several abnormal results purely from statistics: if each test has a 5% chance of a false abnormal, then across a hundred tests almost everyone will have something “found.” What follows is further investigation of noise.
Vitamin and hormone panels with no indication. After 50 it is reasonable to check vitamin D and B12; a “vitamins and trace elements panel” and sex hormones with no specific complaint add no information. The same goes for an annual ultrasound of everything in sight with no symptoms and no risk factors.
Red flags: when it is a doctor, not a checkup
- Blood in the stool, a change in the shape of the stool or in bowel habit lasting more than a few weeks — do not wait for the scheduled stool test, see a doctor.
- Unexplained weight loss of more than 5% over 6–12 months, persistent night sweats, fever with no cause (we covered this in the piece on night sweats and which lab tests to run).
- Chest pain or heaviness on exertion, breathlessness, an irregular heartbeat that has appeared for the first time.
- A lump in the breast, dimpling of the skin or retraction of the nipple, discharge; bleeding after menopause — see a gynecologist in person.
- Difficulty passing urine, blood in the urine, getting up at night to go — a urologist, not a lab panel.
How to build the rhythm: a checkup calendar after 50
| Interval | What |
|---|---|
| Every year | The basic lab set, blood pressure and weight, a doctor’s examination; a fecal immunochemical test, which under international guidance is done annually rather than every two years |
| Every 2 years | Mammography (women 40–74); a stool DNA test, as an alternative, every 1–3 years |
| Every 3 years | Cervical cytology (or an HPV test on the interval agreed with your doctor) |
| Every 5 years | CT colonography or sigmoidoscopy — as an alternative to colonoscopy; HPV testing alone or co-testing for women 30–65 |
| Every 10 years | Colonoscopy (if that is the option chosen and the result is normal) |
| Annually, on indication | Low-dose CT of the lungs: age 50–80, 20 pack-years or more, smoking now or quit less than 15 years ago |
| Once | Ultrasound of the abdominal aorta — men 65–75 who have ever smoked |
| Decided with a doctor | PSA for men; densitometry for all women from 65, earlier when risk factors are present |
As Dr. Aigerim Bissenova stresses, the value of a checkup after 50 is set not by the number of tubes but by whether three or four screenings of proven effectiveness have been carried through to the end. Someone who gives twenty blood tests a year but has been putting off a colonoscopy for ten years is less well examined than someone with a basic set and screenings done on time.
Frequently asked questions
Which lab tests should be done once a year after 50? A sensible annual minimum for most people: a complete blood count, a urinalysis, glucose or glycated hemoglobin, a full lipid panel, creatinine with a calculated eGFR, and liver enzymes — plus blood pressure and weight. TSH and vitamin D are commonly added to that set in everyday practice, although as mass screening tests they are not internationally confirmed. Everything else is added for sex, risk factors and a doctor’s decision, not “for a fuller picture.”
What matters more after 50 — blood tests or screenings? Screenings. Colonoscopy or a stool test for occult blood, mammography, cervical screening, low-dose CT of the lungs in smokers — these are the ones proven to lower mortality. Blood tests are needed too, but they do not replace those examinations, and an extended biochemistry panel does not find cancer.
Does a man over 50 need a PSA test? That is a decision to make together with a doctor. International guidance places PSA screening in men aged 55 to 69 in the shared-decision category: it lowers prostate cancer mortality slightly, but at the cost of false positives, biopsies and overdiagnosis. After 70, routine screening is not recommended. In most places PSA is not part of an organized population program, so the conversation has to be started by you or your doctor.
When should a woman have her bone density checked? Densitometry is recommended for all women from age 65, and in postmenopausal women under 65 when risk factors are present: low body weight, smoking, heavy alcohol use, a parent who fractured a hip. If a fracture after minimal trauma has already happened, or you have been taking glucocorticoids long term, that is no longer screening but a reason for targeted assessment. In men the data for mass screening are insufficient, so the decision is individual.
Are tumor markers worth testing in a checkup after 50? No. Tumor markers are not designed for screening people without symptoms: they often rise in benign conditions and frequently stay normal when a tumor is present. Their place is in monitoring an already established diagnosis. The one qualified exception is PSA, and even then only as a shared decision with a doctor.
How is a checkup after 50 different from the set after 40? After 40 the job is to broaden the base: thyroid, iron, a full lipid panel, HbA1c, vitamins. After 50, systematic cancer screening is layered on top — bowel, lungs in smokers, breast — for women bones and the postmenopausal shift in lipids, and for men the conversation about PSA and a one-off ultrasound of the aorta for anyone who has ever smoked.
Conclusion
A checkup after 50 rests on two supports: a short annual set of lab tests that keeps watch on the vessels, metabolism, kidneys and thyroid, and a handful of screenings on their own schedules that catch tumors and osteoporosis before symptoms appear. Everything else is a question of indications, not of age.
If results have been piling up for years across different labs, that is what we build Wizey for: it helps you gather the markers into one picture, see the trend and put together the questions for your doctor. It is not a substitute for a consultation and not a screening program, but a way of not losing sight of what really does change with age.
